SCHEMBL5814925

SCHEMBL5814925

CCCCOC(=O)N1CC[C](O)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.61
SMN1; SMN2 Q16637 3/20 0.61
POLB P06746 1/20 0.61
HRH2 P25021 5/20 0.45
HRH1 P35367 5/20 0.45
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
ESR1 P03372 3/20 0.40
TSHR P16473 2/20 0.40
SMYD3 Q9H7B4 1/20 0.40
BCHE P06276 1/20 0.40
ATM Q13315 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP2C19 P33261 1/20 0.40
NR1H2 P55055 1/20 0.40
RNASEL Q05823 1/20 0.40
MAPT P10636 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1444915 0.86 SMN1; SMN2 (0.61) LMNASMN1; SMN2POLBHRH2HRH1
SCHEMBL9405372 0.85 POLB (0.73) LMNASMN1; SMN2POLBHRH2HRH1
SCHEMBL8255440 0.85 SMN1; SMN2 (0.59) LMNASMN1; SMN2POLBHRH2HRH1
SCHEMBL1859157 0.82 SMN1; SMN2 (0.69) LMNASMN1; SMN2POLBHRH2HRH1
SCHEMBL3634052 0.82 SMN1; SMN2 (0.69) LMNASMN1; SMN2POLBHRH2HRH1
SCHEMBL861719 0.81 SMN1; SMN2 (0.55) LMNASMN1; SMN2POLBHRH2HRH1
SCHEMBL7838421 0.80 SMN1; SMN2 (0.67) LMNASMN1; SMN2POLBHRH2HRH1
SCHEMBL1826048 0.80 SMN1; SMN2 (0.67) LMNASMN1; SMN2POLBHRH2HRH1
SCHEMBL11492059 0.80 SMN1; SMN2 (0.67) LMNASMN1; SMN2POLBHRH2HRH1
Methyl Alcohol SCHEMBL27443089 0.80 SMN1; SMN2 (0.67) LMNASMN1; SMN2POLBHRH2HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO disclosed